Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.
Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.
Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion.
Fully automated grey and white matter spinal cord segmentation.
Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain.
Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
The devil is in the detail: Acute Guillain-Barré syndrome camouflaged as neurosarcoidosis in a critically ill patient admitted to an Intensive Care Unit.
Mevalonate Cascade and small Rho GTPase in Spinal Cord Injury.
Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Myelination.
A Hedonism Hub in the Human Brain.
Environmental and genetic factors in pediatric inflammatory demyelinating diseases.
The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple Sclerosis.
GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionals.
A multiple sclerosis-like disorder in patients with OPA1 mutations.
Assessment of IL-17A, IL-10 and TGF-beta1 serum titers in RRMS patients treated with Avonex, possible biomarkers for treatment response.
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Therapeutic effect of EDTA in experimental model of multiple sclerosis.

Pages